Novo Integrated Sciences, Inc.
NASDAQ:NVOS
0.2848 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 12.572 | 11.738 | 9.305 | 7.861 | 9.422 | 8.894 | 7.963 | 7.178 | 7.466 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 7.619 | 6.939 | 5.482 | 4.802 | 5.902 | 5.471 | 4.986 | 4.671 | 4.759 | 0 | 0 | 0 | 0 | 0 | 1.871 | 0.827 | 0 | 0 | 0 | 0 |
| Gross Profit
| 4.953 | 4.799 | 3.823 | 3.058 | 3.519 | 3.423 | 2.977 | 2.508 | 2.706 | 0 | 0 | 0 | 0 | 0 | -1.871 | -0.827 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.394 | 0.409 | 0.411 | 0.389 | 0.374 | 0.385 | 0.374 | 0.349 | 0.362 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.147 | 0.209 | 0.109 | 0.136 | 0.291 | 0.255 | 0 | 0 |
| General & Administrative Expenses
| 13.491 | 14.365 | 8.09 | 7.286 | 4.02 | 4.883 | 3.031 | 2.36 | 2.931 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.015 | 0.021 | 0.008 | 0.005 | 0.04 | 0.109 | 0.059 | 0.026 | 0.064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 13.506 | 14.385 | 8.097 | 7.291 | 4.06 | 4.993 | 3.09 | 0.165 | 2.995 | 0 | 0 | 0 | 2.077 | 2.121 | 0 | 0.827 | 2.194 | 1.208 | 1.068 | 0.234 |
| Other Expenses
| 0.608 | 0 | 0.022 | -0.194 | 0.072 | 0 | 0 | 0 | 0.034 | 0.104 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 13.506 | 14.385 | 8.097 | 7.291 | 4.06 | 4.993 | 3.09 | 0.165 | 0.402 | 0.335 | 0.448 | 0.819 | 2.224 | 2.33 | 0.109 | 0.136 | 2.486 | 1.463 | 1.068 | 0.234 |
| Operating Income
| -8.553 | -25.027 | -4.374 | -4.263 | -0.786 | -1.569 | -0.113 | -0.165 | -0.402 | -0.573 | -0.311 | -0.819 | -2.224 | -2.33 | -1.98 | -0.963 | -2.486 | -1.463 | -1.068 | -0.234 |
| Operating Income Ratio
| -0.68 | -2.132 | -0.47 | -0.542 | -0.083 | -0.176 | -0.014 | -0.023 | -0.054 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.392 | -16.082 | -0.077 | -0.568 | 0.204 | -0.548 | -0.521 | 0 | 0.034 | -0.139 | -0.137 | -0.176 | 0.002 | -0.239 | -0.292 | -0.019 | 0.015 | 0 | 0 | -0.048 |
| Income Before Tax
| -13.269 | -33.067 | -4.471 | -4.924 | -0.404 | -2.117 | -0.634 | -0.165 | -2.771 | -1.034 | -0.888 | -1.16 | -2.238 | -2.569 | -2.272 | -0.983 | -2.47 | 0 | 0 | -0.282 |
| Income Before Tax Ratio
| -1.055 | -2.817 | -0.48 | -0.626 | -0.043 | -0.238 | -0.08 | -0.023 | -0.371 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 5.67 | -0.022 | 0.178 | -0.046 | 0.283 | 0.008 | 0.112 | -0.073 | 2.403 | 0.802 | 0.44 | 0.166 | 0.016 | 0 | 0 | 0 | 0 | 0.002 | 0.001 | 0 |
| Net Income
| -13.215 | -32.849 | -4.462 | -4.915 | -0.392 | -2.108 | -0.738 | -0.165 | -2.771 | -1.034 | -0.888 | -1.16 | -2.238 | -2.569 | -2.272 | -0.983 | -2.47 | -1.465 | -1.069 | -0.282 |
| Net Income Ratio
| -1.051 | -2.799 | -0.48 | -0.625 | -0.042 | -0.237 | -0.093 | -0.023 | -0.371 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.3 | -11.28 | -1.8 | -2.13 | -0.18 | -1.02 | -0.42 | -0.74 | -13.29 | -6.36 | -11.46 | -35.24 | -85.4 | -118.79 | -153.65 | -104.08 | -322.75 | -238.34 | -184.71 | -50.25 |
| EPS Diluted
| -1.3 | -11.28 | -1.8 | -2.13 | -0.18 | -1.02 | -0.42 | -0.74 | -13.29 | -6.36 | -11.46 | -35.24 | -85.4 | -118.79 | -153.65 | -104.08 | -322.75 | -238.34 | -184.71 | -50.25 |
| EBITDA
| -5.634 | -6.398 | -2.482 | -2.948 | -0.216 | -1.479 | -0.011 | -0.165 | -0.401 | -0.087 | -0.307 | -0.814 | -2.22 | -2.325 | -1.974 | -0.945 | -2.474 | -1.461 | -1.067 | -0.209 |
| EBITDA Ratio
| -0.448 | -0.545 | -0.267 | -0.375 | -0.023 | -0.166 | -0.001 | -0.023 | -0.054 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |